Povidone iodine/hydrogen peroxide chronic use studies needed for antigingival claims.
This article was originally published in The Rose Sheet
Executive Summary
POVIDONE IODINE/HYDROGEN PEROXIDE RINSE CHRONIC USE STUDIES NEEDED to support antigingival claims for the product, FDA's Dental Products Panel Plaque Subcommittee agreed at a May 8-9 meeting in Bethesda, Md. The subcommittee conclusion followed a presentation by Gunning Point Consulting Group Director Samuel Trotz, PhD, on behalf of Perimed, the manufacturer of Perimed oral rinse.